Huiam Mubarak, MD

Lindsay Frerichs, MD, is a neurologist in the Lewis Headache Center and an assistant professor in the Department of Neurology at Barrow Neurological Institute. She is board certified in neurology by the American Board of Psychiatry and Neurology and in headache medicine by the United Council for Neurologic Subspecialties. Dr. Frerichs’ expertise includes diagnosing and treating migraine, cluster headache, intracranial hypotension, idiopathic intracranial hypertension, trigeminal neuralgia, and occipital neuralgia. In addition to managing headache disorders with medication, she is experienced in nerve block and Botox procedures. She is a member of the American Academy of Neurology, the American Headache Society, the Headache Cooperative of the Pacific, and the Southern Headache Society. Dr. Frerichs earned her medical degree from the University of Texas Health Science Center in San Antonio. She completed her neurology residency at Washington University in St. Louis, Missouri and a fellowship in headache medicine at University of Texas Southwestern in Dallas.

Ruchira Jha, MD, MSc, is the division chief of Neurocritical Care, medical director of the Neurointensive Care Unit, and a professor in the departments of Neurology, Neurosurgery, and Translational Neuroscience at Barrow Neurological Institute. She is a clinical neurointensivist. She is board certified in neurology by the American Board of Psychiatry and Neurology and in neurocritical care by the United Council for Neurologic Subspecialties. Dr. Jha’s expertise includes clinical and translational research in neurotrauma and neurocritical care. She is a member of the American Academy of Neurology, the American Neurological Association, the National Neurotrauma Society, the Neurocritical Care Society, the Society for Neuroscience, and the Society of Critical Care Medicine. Dr. Jha earned her medical degree from Harvard Medical School in Boston, Massachusetts. She also earned a Master of Science degree in clinical and translational research from the University of Pittsburgh in Pennsylvania. Dr. Jha completed her neurology residency, chief residency, and a fellowship in neurocritical care at Massachusetts General Hospital and Brigham & Women’s Hospital through the Harvard Medical School Partners Program. Dr. Jha has received prestigious awards from the National Institutes of Health (NIH) and other foundations to pursue her research. She uses a translational approach to evaluate and develop individualized targets against cerebral edema to improve outcomes after traumatic brain injury (TBI). She has multiple publications and national presentations in this field. She is also involved in collaborations with multicenter TBI consortia, such as TRACK TBI and GAIN (Genetic Associations in Neurotrauma), for her research. Dr. Jha serves on the editorial board of JAMA Neurology and is the critical care section editor for the journal Stroke.

Anna Burke, MD, is a geriatric psychiatrist and the director of neuropsychiatry at Barrow Neurological Institute. She is board certified in psychiatry with a subspecialty certification in geriatric psychiatry by the American Board of Psychiatry and Neurology. Dr. Burke’s expertise includes the treatment of challenging behavioral and psychiatric disturbances that result from neurological conditions. She is a member of the American Association for Geriatric Psychiatry, the Alzheimer’s Association International Society to Advance Alzheimer’s Research and Treatment, and the Arizona Geriatrics Society. Dr. Burke received her medical degree from Gdańsk Medical University. She completed her residency training in adult psychiatry at Hartford Hospital’s Institute of Living before completing a geriatric psychiatry fellowship at McLean Hospital, the largest psychiatric teaching hospital of Harvard Medical School. In addition to her clinical work, Dr. Burke has led numerous clinical trials of investigational drugs, neuromodulation, environmental modifications, prevention methods, and novel neuroimaging techniques for cognitively impaired patients with neurodegenerative disorders.